Neha Krishnamohan
Fortune : 2 M $ au 30/06/2026
Fortune : 2 M $ au 30/06/2026
Neha Krishnamohan is currently an Independent Director at Arcutis Biotherapeutics, Inc. since 2022 and Chief Financial & Business Officer at Latigo Biotherapeutics, Inc. starting in 2026.
Former roles include CFO & Executive VP-Corporate Development at Artiva Biotherapeutics, Inc. from 2024 to 2025, CFO & Executive VP-Corporate Development at Kinnate Biopharma, Inc. from 2021 to 2024, and Vice President-Healthcare Investment Banking at The Goldman Sachs Group, Inc. from 2015 to 2021.
Education includes undergraduate studies at Duke University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/11/2025 | 99 356 ( 0,2 % ) | 963 753 $ | 30/06/2026 | |
| 05/06/2026 | 22 123 ( 0,02 % ) | 580 065 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Directeur/Membre du Conseil | 02/09/2022 |
Latigo Biotherapeutics, Inc.
Latigo Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company that develops non-opioid pain medicines | Directeur Financier/CFO | 01/02/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
| ARTIVA BIOTHERAPEUTICS, INC. | Directeur Financier/CFO | 31/12/2025 |
| KINNATE BIOPHARMA INC. | Directeur Financier/CFO | 03/04/2024 |
| THE GOLDMAN SACHS GROUP, INC. | Corporate Officer/Principal | 01/05/2021 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
The Goldman Sachs Group, Inc.
The Goldman Sachs Group, Inc. Investment Banks/BrokersFinance Provides investment banking, asset, wealth management and platform services | Finance |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arcutis Biotherapeutics, Inc.
Arcutis Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an immunodermatology drug development company | Health Technology |
Kinnate Biopharma, Inc.
Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage precision oncology company | Health Technology |
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. Pharmaceuticals: OtherHealth Technology Operates as a biotechnology company which develops natural killer cell-based therapies for patients suffering from autoimmune diseases and cancers | Health Technology |
Latigo Biotherapeutics, Inc.
Latigo Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company that develops non-opioid pain medicines | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national